Back to search
Female Sexual Interest/Arousal Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Female Sexual Interest/Arousal Disorder trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Female Sexual Interest/Arousal Disorder trials you may qualify forHypoactive sexual desire disorder (HSDD) is described as the most common form of female sexual dysfunction, particularly affecting peri- and postmenopausal wome…
Ospemifene is the first oral and non-hormonal treatment for moderate or severe vulvo-vaginal atrophy (VVA) in postmenopausal women who are not candidates to tre…